Glossary
Analyst Ratings
1-Strong Buy4
2-Buy5
3-Hold0
4-Underperform0
5-Sell0
Mean Recommendation: 1.6

Buy
SellStrong Buy
Analyst Forecasts - EPS
 Last Month Revisions
Fiscal Period MeanHighLowMedian# of Estimates#Up#DownMean % Change
AnnualDec 150.611.000.110.56705-18.10
AnnualDec 140.070.84-0.400.00815250.00
AnnualDec 13-0.32-0.07-0.40-0.37816N/A
QuarterlyJun 13-0.10-0.06-0.12-0.1180623.98
QuarterlySep 13-0.080.15-0.13-0.118151.67
QuarterlyDec 13-0.11-0.10-0.14-0.1180533.82
QuarterlyMar 14-0.10-0.03-0.14-0.12402122.22
Long Term Growth N/AN/AN/AN/AN/AN/AN/AN/A
Actuals - EPS
  Reported EPSMean EstimateSurprise % Change
AnnualDec 12-0.32-0.30-8.02
QuarterlyJun 12-0.02-0.0978.79
QuarterlySep 12-0.08-0.07-9.80
QuarterlyDec 12-0.09-0.08-20.00
QuarterlyMar 13-0.03-0.01-350.00
AnnualDec 11-0.42-0.456.41
AnnualDec 10-0.34-0.32-7.59
Data Provided by Thomson Reuters


Copyright © 2013 by Keryx Biopharmaceuticals, Inc.
Update Notice | Disclaimer | Contact Us